Ryosuke Tajiri

452 total citations
27 papers, 311 citations indexed

About

Ryosuke Tajiri is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ryosuke Tajiri has authored 27 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ryosuke Tajiri's work include Cancer-related gene regulation (4 papers), Soft tissue tumor case studies (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Ryosuke Tajiri is often cited by papers focused on Cancer-related gene regulation (4 papers), Soft tissue tumor case studies (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Ryosuke Tajiri collaborates with scholars based in Japan, United States and Sweden. Ryosuke Tajiri's co-authors include Akishi Ooi, Yoh Dobashi, Takashi Fujimura, Shioto Suzuki, Takeru Oyama, Ritsuko Nakamura, Carl Henrik Heldin, Sadaki Yokota, Hiroko Ikeda and Ryo Munakata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Ryosuke Tajiri

22 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Tajiri Japan 8 127 104 93 65 61 27 311
Bérengère Dadone France 11 178 1.4× 120 1.2× 172 1.8× 102 1.6× 39 0.6× 17 377
Kanae Nosaka Japan 12 178 1.4× 153 1.5× 135 1.5× 98 1.5× 59 1.0× 36 425
Jin Haeng Chung South Korea 13 148 1.2× 153 1.5× 105 1.1× 61 0.9× 123 2.0× 36 435
T. R. J. Evans United Kingdom 11 216 1.7× 134 1.3× 87 0.9× 41 0.6× 106 1.7× 25 467
Ehab Husain United Kingdom 11 118 0.9× 135 1.3× 57 0.6× 129 2.0× 67 1.1× 25 398
Hiroyuki Hiraki Japan 10 109 0.9× 97 0.9× 171 1.8× 36 0.6× 68 1.1× 15 372
Rosa Rinaldi Italy 13 116 0.9× 179 1.7× 110 1.2× 143 2.2× 71 1.2× 36 421
Clarence Eng United States 8 131 1.0× 130 1.3× 79 0.8× 158 2.4× 49 0.8× 16 342
Carolina Moreno Brazil 8 123 1.0× 78 0.8× 65 0.7× 29 0.4× 32 0.5× 12 331
Anna Estival Spain 12 63 0.5× 161 1.5× 174 1.9× 44 0.7× 30 0.5× 37 316

Countries citing papers authored by Ryosuke Tajiri

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Tajiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Tajiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Tajiri more than expected).

Fields of papers citing papers by Ryosuke Tajiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Tajiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Tajiri. The network helps show where Ryosuke Tajiri may publish in the future.

Co-authorship network of co-authors of Ryosuke Tajiri

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Tajiri. A scholar is included among the top collaborators of Ryosuke Tajiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Tajiri. Ryosuke Tajiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amemiya, Kenji, Yosuke Hirotsu, Yuji Iimuro, et al.. (2025). Decoding Genomic Diversity to Guide Tumor Lesion‐Specific Treatment of Multifocal Hepatocellular Carcinoma. Cancer Medicine. 14(7). e70814–e70814. 1 indexed citations
2.
Sakamoto, Ikuko, Keiko Kagami, Kenji Amemiya, et al.. (2025). Preoperative molecular classification of endometrial cancer: Validation through biopsy and matched hysterectomy specimens. Gynecologic Oncology. 203. 105–111.
3.
Tajiri, Ryosuke, et al.. (2024). Secondary syphilis in the third trimester of pregnancy. SHILAP Revista de lepidopterología. 12(3). e8570–e8570. 2 indexed citations
4.
Inaba, Atsushi, Nobuya Ohishi, Yusuke Sugiyama, et al.. (2024). An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC Pulmonary Medicine. 24(1). 336–336.
5.
Yamamoto, Megumi, Shohei Shimajiri, Hiroshi Mori, et al.. (2024). Evaluation of expression of amino acid and fatty acid metabolic transporters in the placenta of pregnant women with glucose intolerance. Journal of obstetrics and gynaecology research. 51(1). e16163–e16163.
6.
Komatsu, Kazuki, Eisuke Shiba, Aya Nawata, et al.. (2023). PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors. Modern Pathology. 36(3). 100070–100070. 16 indexed citations
7.
Shimizu, Kaori, Masaru Hosone, Keiko Nakamura, et al.. (2023). An autopsy case of HHV8 negative common effusion lymphoma that developed during treatment for lung carcinoma. The Journal of the Japanese Society of Clinical Cytology. 62(2). 98–104.
9.
Hachisuga, Toru, Hiroshi Harada, Tomoko Kurita, et al.. (2022). Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas. Scientific Reports. 12(1). 3153–3153. 3 indexed citations
10.
Boyraz, Bariş, Ryosuke Tajiri, Arnaud Da Cruz Paula, et al.. (2022). Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1‐CYP2E1 fusions. Histopathology. 81(6). 841–846. 2 indexed citations
11.
Tajiri, Ryosuke, Eisuke Shiba, Aya Nawata, et al.. (2021). Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1-CYP2E1 fusion. Modern Pathology. 34(12). 2222–2228. 10 indexed citations
12.
Kawahara, Takashi, et al.. (2020). Renal Squamous Cell Carcinoma with Staghorn Calculus. Case Reports in Oncology. 13(1). 403–407. 4 indexed citations
13.
Kawahara, Takashi, et al.. (2019). IgG4-Producing MALT Lymphoma in the Renal Hilum. Case Reports in Oncology. 12(3). 880–884. 2 indexed citations
15.
Kawahara, Takashi, et al.. (2019). Retroperitoneal Castleman’s Disease. Case Reports in Oncology. 12(3). 885–889. 5 indexed citations
16.
Ooi, Akishi, Takeru Oyama, Ritsuko Nakamura, et al.. (2015). Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. Modern Pathology. 28(6). 861–871. 17 indexed citations
17.
Tajiri, Ryosuke, Masafumi Inokuchi, Seiko Sawada‐Kitamura, et al.. (2014). Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation‐dependent probe amplification and fluorescence in situ hybridization. Pathology International. 64(5). 231–236. 2 indexed citations
19.
Suzuki, Shioto, Yoh Dobashi, Hiroshi Minato, et al.. (2012). EGFR and HER2–Akt–mTOR signaling pathways are activated in subgroups of salivary gland carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(3). 271–282. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026